Adjuvant low-dose rituximab and plasma exchange for acquired TTP

Podobne knjige/članki

• Severe primary refractory thrombotic thrombocytopenic purpura (TTP) in the post plasma exchange (PEX) and rituximab era
  od: Goranta, Sowmya, et al.
  Izdano: (2020)
• Caplacizumab in adult patients with acquired thrombotic thrombocytopenic purpura
  od: Hanlon, Ashley, et al.
  Izdano: (2020)
• Rituximab leads to early elimination of circulating CD20(+) T and B lymphocytes in patients with iTTP despite ongoing TPEx
  od: Carden, Marcus A., et al.
  Izdano: (2020)
• OUTCOMES OF PATIENTS WITH WORSENING ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) DESPITE DAILY THERAPEUTIC PLASMA EXCHANGE IN THE PHASE 3 HERCULES TRIAL
  od: M. Scully, et al.
  Izdano: (2020-11-01)
• Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide vs. Rituximab
  od: Abou-Ismail, Mouhamed Yazan, et al.
  Izdano: (2020)